Related Experiment Video
Updated: Jun 17, 2025

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
Published on: December 4, 2016
Hyperbranched Polymeric 19F MRI Contrast Agents with Long T2 Relaxation Time Based on β-Cyclodextrin and
Jialei Han1, Ziwei Duan1, Changjiang Liu1
1School of Biomedical Engineering, Sun Yat-Sen University of Shenzhen Campus, Shenzhen 518107, China.
A new hyperbranched polymer acts as a 19F MRI contrast agent (CA). This novel CA demonstrates high fluorine content and excellent biocompatibility for advanced in vivo imaging applications.
Area of Science:
- Biomedical Engineering
- Materials Science
- Radiology
Background:
- 19F magnetic resonance imaging (19F MRI) is an emerging diagnostic technology.
- Effective 19F MRI contrast agents (CAs) require long transverse relaxation times (T2), short longitudinal relaxation times (T1), high fluorine content, and good biocompatibility.
Purpose of the Study:
- To develop and characterize a novel hyperbranched polymeric 19F MRI CA.
- To investigate the impact of branching degree and fluorine content on CA performance.
Main Methods:
- Synthesis of a hyperbranched polymer CA using β-cyclodextrin and phosphorylcholine.
- Evaluation of fluorine content, relaxation times (T1 and T2), and biocompatibility.
- In vitro and in vivo imaging studies.
Main Results:
- The novel CA achieved a maximum fluorine content of 11.85%.
- A significantly long T2 relaxation time of 612 ms was observed.
- The CA demonstrated excellent biocompatibility and high-performance imaging capabilities.
Conclusions:
- The developed hyperbranched polymeric CA shows promise for 19F MRI.
- This research offers insights into designing effective 19F MRI contrast agents through synthesis strategies and topological design.
More Related Videos
13:21Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging
Published on: July 21, 2011
14:01Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
Published on: July 22, 2011